DISHMAN CARBOGEN AMCIS Share Price Up by 5%; BSE HEALTHCARE Index Down 0.1%
September 16, 2021 12:19 PM

DISHMAN CARBOGEN AMCIS share price has zoomed 5% and is presently trading at Rs 221.

Meanwhile, the BSE HEALTHCARE Index is at 26,979 (down 0.1%).

Among the top Gainers in the BSE HEALTHCARE Index today is DISHMAN CARBOGEN AMCIS (up 5.5%).

J.B.CHEMICALS and DR. REDDYS LAB (down 0.1%) are among the top losers today.

Over the last one year, DISHMAN CARBOGEN AMCIS has moved up from Rs 169 to Rs 221, registering a gain of Rs 52 (up 30.1%).

On the other hand, the BSE HEALTHCARE has moved up from 18,952 to 26,979, registering a gain of 8,027 points (up 41.7%) during the last 12 months.

The top buzzing stocks among the BSE HEALTHCARE Index stocks during this same period were APOLLO HOSPITALS (up 196.3%), LAURUS LABS (up 144.8%) and DR. LAL PATHLABS (up 111.6%).

What About the Benchmark Indices?

The BSE Sensex is at 58,974 (up 0.4%).

The top gainers among the BSE Sensex stocks today are INDUSIND BANK (up 9.0%), ITC (up 6.9%) and SBI (up 2.3%). Other gainers include RELIANCE IND. (up 1.8%) and POWER GRID (up 1.3%). The most traded stocks in the BSE Sensex are ITC and INDUSIND BANK.

In the meantime, NSE Nifty is at 17,581 (up 0.3%). The top gainers in the NSE Nifty include INDUSIND BANK (up 9.2%), ITC (up 6.9%) and SBI (up 2.5%). Other gainers include RELIANCE IND. (up 1.8%) and POWER GRID (up 1.3%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 38,757 to 58,974, registering a gain of 20,217 points (up 52.12%).

DISHMAN CARBOGEN AMCIS Financial Update...

DISHMAN CARBOGEN AMCIS net profit declined 199.7% YoY to Rs 160 million for the quarter ended June 2021, compared to a loss of Rs 161 million a year ago. Net Sales rose 17.5% to Rs 5.5 billion during the period as against Rs 4.7 billion in April-June 2020.

For the year ended March 2021, DISHMAN CARBOGEN AMCIS reported 204.2% decrease in net profit to Rs 1.7 billion compared to net profit of Rs 1.6 billion during FY20.

Revenue of the company grew 6.4% to Rs 19 billion during FY21.

The current Price to earnings ratio of DISHMAN CARBOGEN AMCIS, based on rolling 12 month earnings, stands at down 27.0x.